Q-omics provides the consensus-scored TPTEP2-CSNK1E profile across patient tissues and cancer cell-line models. Additionally, TPTEP2-CSNK1E RNA expression shows 2,582 significant protein co-abundance associations, with the highest sampling consensus in GBM.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for TPTEP2-CSNK1E — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with TPTEP2-CSNK1E in patient tissues and cancer cell lines. In patient samples, TPTEP2-CSNK1E shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set. In cancer cell lines, TPTEP2-CSNK1E RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SOFT_TISSUE, while CRISPR and shRNA rows add functional-dependency signals in BLOOD_Leukemia.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	2,582	GBM (558)	view →
Function (mass-spec)	165	LSCC (43)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
shRNA	2,012	SOFT_TISSUE (299)	view →
RNA	1,901	BLOOD_Leukemia (486)	view →